🐜
|
Session C: Molecular Oncology, Diagnostics and Pharmacology C1 A NOVEL CANDIDATE GENE IN HUMAN ENDOMETRIAL CANCER AT CHROMOSOME 10Q26 IN AND OF PATIENTS WITH NON-SMALL-CELL LUNG CANCER (NSCLC) (EGFR) INHIBITOR GEFITINIB AND THE MAMMALIAN TARGET OF RAPAMYCIN (MTOR) INHIBITOR EVEROLIMUS
69 auth.
P. Baldinu,
A. Cossu,
A. Manca,
M. Sini,
M. Satta,
M. Casula,
C. Rozzo,
M. Pisano,
M. Colombino,
G. Palomba,
P. P. Demuro,
M. F. Dedola,
S. Dessole,
A. Pintus,
A. Carboni,
...
A. Deiana,
F. Tanda,
G. Palmieri,
L. Pistola,
V. Ludovini,
V. Gregorc,
G. Bellezza,
S. Darwish,
E. Rulli,
A. Compagnoni,
A. Sidoni,
M. Scheibel,
Z. Myhailova,
M. Ragusa,
L. .. Carlo,
F. Tofanetti,
M. Bellet,
M. Ferraldeschi,
G. Daddi,
M. Tonato,
Serena,
Di,
Cosimo,
Pablo,
Matar,
Federico,
Rojo,
Marta,
Guzmán,
Sonia,
Rodríguez,
José,
Jimenez,
Érika,
Martinelli,
Joaquín,
Arribas,
Heidi,
Lane,
F. Cognetti,
J. Baselga,
R. Passera,
E. Ferrarato,
M. Franco,
L. Delprino,
R. Divella,
Elvira Foglia Manzillo,
I. Lolli,
Rosa Crollo,
M. Ronco,
L. Ercolino,
Franco Pascazio,
L. Melpignano,
G. Troccoli
|
0 |
2004 |
0 🐜
|